07 Oct 2016 --- A new study has demonstrated that synthesis-derived MK-7 is 100% bioequivalent to fermentation-derived MK-7, in both biological function and activity. The new development is expected to please the K2 MK7 supplements industry, as production by batch fermentation restricts the manufacturing scalability of MK-7, restricting overall growth of the vitamin K2 market.
